Table 1 Demographic and clinical symptom data for confirmed mpox cases (n = 9) and suspected mpox (n = 170) identified in the Goma region to date
From: First imported cases of MPXV Clade Ib from Goma, Democratic Republic of the Congo
Characteristic | Confirmed Mpox Cases (n = 9) | Suspect Mpox cases (n = 170) | ||
|---|---|---|---|---|
N | % | N | % | |
Reported health zone | ||||
Goma HZ | 0 | 0.0 | 114 | 67.1 |
Karisimbi HZ | 0 | 0.0 | 42 | 24.7 |
Nyiragongo HZ | 5 | 55.6 | 0 | 0.0 |
Not specified | 4 | 44.4 | 14 | 8.2 |
Sex | ||||
Male | 5 | 55.6 | 94 | 55.3 |
Female | 4 | 44.4 | 75 | 44.1 |
Not reported | 0 | 0.0 | 1 | 0.6 |
Age group | ||||
<15 | 3 | 33.3 | 48 | 28.2 |
15–30 | 5 | 55.6 | 87 | 51.2 |
>30 | 1 | 11.1 | 33 | 19.4 |
Clinical symptoms | ||||
Cutaneous eruptions | 9 | 100.0 | 157 | 92.4 |
Genital eruptions | 7 | 77.8 | 45 | 26.5 |
Oral eruptions | 6 | 66.7 | 17 | 10.0 |
Fever | 6 | 66.7 | 140 | 82.4 |
Headache | 7 | 77.8 | 78 | 45.9 |
Myalgia | 8 | 88.9 | 52 | 30.6 |
Arthralgia | 7 | 77.8 | 43 | 25.3 |
Fatigue | 3 | 33.3 | 60 | 35.3 |
Cervical lymphadenopathy | 7 | 77.8 | 40 | 23.5 |
Inguinal lymphadenopathy | 5 | 55.6 | 38 | 22.4 |
Axillary lymphadenopathy | 3 | 33.3 | 31 | 18.2 |
Hospitalization | 6 | 66.7 | 103 | 60.6 |
